Expert biotech CPA services in New York City by Stewart Robinson, CPA. Get financial analysis, tax help, and funding strategies.
According to the city's Economic Development Corp., the city has 120 early- to mid-stage companies focused on medical devices. Jonathan Bowles, director at the Center for an Urban Future, comments that the ...
Situated in Valhalla, New York, BioInc@NYMC offers quick, convenient access to Manhattan in New York City. Centrally located in the NY BioHud Valley innovation hub Easily accessible by car, public transportation, bus or commuter rail Close proximity to LaGuardia Airport, John F. Kennedy Internat...
NILO Therapeutics|New York City, New York Apply Promote your job Select role All roles Select category Select state(s) All states Select state(s) Select company (type 1st letter) All companies Select company (type 1st letter) Job Title ...
She was also instrumental in the company’s private and public financing activities. Prior to that, Dr. Dong was the Managing Director of Vivo Capital, the General Partner of Vivo PANDA Fund and Innovation Fund II. She incubated biotec...
NEW YORK,Feb. 7, 2024/PRNewswire/ -- Scion Life Sciences ("Scion"), an affiliate of Petrichor, is aNew York City-based life sciences venture capital firm dedicated to founding and building exceptional biotechnology companies that discover, develop, ...
Big4Bio found the mood at JPM to be more optimistic than in 2024, which was exemplified by a large attendance of companies, investors, and service providers actively engaging with each other throughout the week. Read More Browse Our Regional Company Directories Whether you're seeking potential...
Big4Bio found the mood at JPM to be more optimistic than in 2024, which was exemplified by a large attendance of companies, investors, and service providers actively engaging with each other throughout the week. Read More Browse Our Regional Company Directories Whether you're seeking potential...
SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EPR BIOTECH NEWS/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around...
It will be the first time that Miller, who has founded nine other companies in his over 30-year career, has ever launched a drug. Previously, he’s always sold the company before that point, the CEO said. But he doesn’t see that for Apnimed. The team of almost 30, which operates...